SCHEMBL6745114

SCHEMBL6745114

Cc1cccc(C2=CCC=C2c2cc(F)c(S(C)(=O)=O)c(F)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SDHB P21912 1/20 0.38
PTGS2 P35354 2/20 0.35
PTGS1 P23219 1/20 0.35
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
RPS6KA3 P51812 1/20 0.33
RECQL P46063 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
ACHE P22303 1/20 0.33
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
CASP1 P29466 1/20 0.32
DPP4 P27487 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
PTPN5 P54829 1/20 0.31
MAPK14 Q16539 2/20 0.31
GALR1 P47211 1/20 0.31
GRM5 P41594 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746349 0.87 PTGS2 (0.41) PTGS2PTGS1CASP1
SCHEMBL6746288 0.87 CASP1 (0.35) PTGS2CASP1
SCHEMBL6745120 0.85 ACLY (0.35) SDHBPTGS2PTGS1NR1H2NR1H3
SCHEMBL6743237 0.85 PTGS2 (0.38) PTGS2PTGS1CASP1
SCHEMBL6746293 0.85 PTGS2 (0.38) PTGS2CASP1CA1CA2GALR1
SCHEMBL6746753 0.84 PTGS2 (0.45) SDHBPTGS2PTGS1CASP1
SCHEMBL6746730 0.83 PTGS2 (0.38) PTGS2AKR1C3AKR1C2CASP1
SCHEMBL6749791 0.83 PTGS2 (0.40) PTGS2AKR1C3AKR1C2CA1CA2
SCHEMBL6750004 0.82 PTGS2 (0.46) PTGS2PTGS1CASP1
SCHEMBL6747309 0.82 PTGS2 (0.47) PTGS2PTGS1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US claimed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US disclosed